Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $8.50 billion. The enterprise value is $8.41 billion.
Important Dates
The last earnings date was Monday, February 23, 2026, before market open.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 51.15 million shares outstanding. The number of shares has increased by 3.83% in one year.
| Current Share Class | 51.15M |
| Shares Outstanding | 51.15M |
| Shares Change (YoY) | +3.83% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 75.67% |
| Float | 43.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.33 |
| Forward PS | 8.34 |
| PB Ratio | 95.88 |
| P/TBV Ratio | 238.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 2.47.
| Current Ratio | 1.55 |
| Quick Ratio | 1.44 |
| Debt / Equity | 2.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.63 |
Financial Efficiency
Return on equity (ROE) is -252.11% and return on invested capital (ROIC) is -38.02%.
| Return on Equity (ROE) | -252.11% |
| Return on Assets (ROA) | -16.81% |
| Return on Invested Capital (ROIC) | -38.02% |
| Return on Capital Employed (ROCE) | -54.42% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | $690,266 |
| Profits Per Employee | -$198,026 |
| Employee Count | 925 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 2.17 |
Taxes
| Income Tax | -530,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.93% in the last 52 weeks. The beta is 0.40, so AXSM's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +29.93% |
| 50-Day Moving Average | 174.51 |
| 200-Day Moving Average | 133.75 |
| Relative Strength Index (RSI) | 36.66 |
| Average Volume (20 Days) | 604,769 |
Short Selling Information
The latest short interest is 2.71 million, so 5.31% of the outstanding shares have been sold short.
| Short Interest | 2.71M |
| Short Previous Month | 2.71M |
| Short % of Shares Out | 5.31% |
| Short % of Float | 6.28% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, AXSM had revenue of $638.50 million and -$183.17 million in losses. Loss per share was -$3.68.
| Revenue | 638.50M |
| Gross Profit | 591.02M |
| Operating Income | -169.24M |
| Pretax Income | -183.70M |
| Net Income | -183.17M |
| EBITDA | -160.17M |
| EBIT | -169.24M |
| Loss Per Share | -$3.68 |
Full Income StatementBalance Sheet
The company has $322.93 million in cash and $218.11 million in debt, with a net cash position of $104.82 million or $2.05 per share.
| Cash & Cash Equivalents | 322.93M |
| Total Debt | 218.11M |
| Net Cash | 104.82M |
| Net Cash Per Share | $2.05 |
| Equity (Book Value) | 88.30M |
| Book Value Per Share | 1.74 |
| Working Capital | 210.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$93.41 million and capital expenditures -$480,000, giving a free cash flow of -$93.89 million.
| Operating Cash Flow | -93.41M |
| Capital Expenditures | -480,000 |
| Free Cash Flow | -93.89M |
| FCF Per Share | -$1.84 |
Full Cash Flow StatementMargins
Gross margin is 92.56%, with operating and profit margins of -26.51% and -28.69%.
| Gross Margin | 92.56% |
| Operating Margin | -26.51% |
| Pretax Margin | -28.77% |
| Profit Margin | -28.69% |
| EBITDA Margin | -25.09% |
| EBIT Margin | -26.51% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.83% |
| Shareholder Yield | -3.83% |
| Earnings Yield | -2.15% |
| FCF Yield | -1.10% |
Analyst Forecast
The average price target for AXSM is $209.18, which is 25.82% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $209.18 |
| Price Target Difference | 25.82% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 37.66% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 3.67 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.67 |
| Piotroski F-Score | 4 |
